カテゴリー： QYResearch, 世界

世界の核医学＆放射性医薬品市場 2019年

【英語タイトル】Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X12120）・商品コード：DATA909X12120
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2025年版があります。お問い合わせください）
・ページ数：100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥525,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥787,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,050,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、核医学＆放射性医薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、診断薬：SPECT放射性医薬品、PET放射性医薬品、治療薬：ベータエミッター、アルファエミッター、近接照射療法アイソトープに、用途別には、診断用途：SPECT、PET、治療用途：甲状腺、骨転移、リンパ腫、内分泌腫瘍、その他の治療用途にセグメント区分し、核医学＆放射性医薬品の世界市場を分析しました。


・エグゼクティブ・サマリー
・核医学＆放射性医薬品の世界市場概要
・核医学＆放射性医薬品の製造コスト構成分析
・核医学＆放射性医薬品の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・核医学＆放射性医薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・核医学＆放射性医薬品のセグメント分析（種類別）
（診断薬：SPECT放射性医薬品、PET放射性医薬品、治療薬：ベータエミッター、アルファエミッター、近接照射療法アイソトープ）
・核医学＆放射性医薬品のセグメント分析（用途別）
（診断用途：SPECT、PET、治療用途：甲状腺、骨転移、リンパ腫、内分泌腫瘍、その他の治療用途）
・核医学＆放射性医薬品の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（GE Healthcare、Philips Healthcare、Siemens Healthcare、Toshiba、Hitachi、Carestream、Esaote、Shimadzu、TriFoil Imaging、Biosensors International Group, Ltd、）
・核医学＆放射性医薬品の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Nuclear Medicine & Radio Pharmaceuticals market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Nuclear Medicine & Radio Pharmaceuticals volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nuclear Medicine & Radio Pharmaceuticals market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Nuclear Medicine & Radio Pharmaceuticals in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Nuclear Medicine & Radio Pharmaceuticals manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
GE Healthcare
Philips Healthcare
Siemens Healthcare
Toshiba
Hitachi
Carestream
Esaote
Shimadzu
TriFoil Imaging
Biosensors International Group, Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

Segment by Application
Diagnostic Applications: SPECT, PET.
Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Nuclear Medicine & Radio Pharmaceuticals
1.1 Definition of Nuclear Medicine & Radio Pharmaceuticals
1.2 Nuclear Medicine & Radio Pharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
1.2.3 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
1.3 Nuclear Medicine & Radio Pharmaceuticals Segment by Applications
1.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Comparison by Applications (2014-2025)
1.3.2 Diagnostic Applications: SPECT, PET.
1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
1.4 Global Nuclear Medicine & Radio Pharmaceuticals Overall Market
1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue (2014-2025)
1.4.2 Global Nuclear Medicine & Radio Pharmaceuticals Production (2014-2025)
1.4.3 North America Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2014-2025)
1.4.4 Europe Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2014-2025)
1.4.5 China Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2014-2025)
1.4.6 Japan Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2014-2025)
1.4.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2014-2025)
1.4.8 India Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals
2.3 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
2.4 Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals

3 Development and Manufacturing Plants Analysis of Nuclear Medicine & Radio Pharmaceuticals
3.1 Capacity and Commercial Production Date
3.2 Global Nuclear Medicine & Radio Pharmaceuticals Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Nuclear Medicine & Radio Pharmaceuticals
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Nuclear Medicine & Radio Pharmaceuticals Production and Capacity Analysis
4.2 Nuclear Medicine & Radio Pharmaceuticals Revenue Analysis
4.3 Nuclear Medicine & Radio Pharmaceuticals Price Analysis
4.4 Market Concentration Degree

5 Nuclear Medicine & Radio Pharmaceuticals Regional Market Analysis
5.1 Nuclear Medicine & Radio Pharmaceuticals Production by Regions
5.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Production by Regions
5.1.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions
5.2 Nuclear Medicine & Radio Pharmaceuticals Consumption by Regions
5.3 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.3.1 North America Nuclear Medicine & Radio Pharmaceuticals Production
5.3.2 North America Nuclear Medicine & Radio Pharmaceuticals Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.4 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.4.1 Europe Nuclear Medicine & Radio Pharmaceuticals Production
5.4.2 Europe Nuclear Medicine & Radio Pharmaceuticals Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.5 China Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.5.1 China Nuclear Medicine & Radio Pharmaceuticals Production
5.5.2 China Nuclear Medicine & Radio Pharmaceuticals Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.6 Japan Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.6.1 Japan Nuclear Medicine & Radio Pharmaceuticals Production
5.6.2 Japan Nuclear Medicine & Radio Pharmaceuticals Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.7 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.7.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production
5.7.2 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Import and Export
5.8 India Nuclear Medicine & Radio Pharmaceuticals Market Analysis
5.8.1 India Nuclear Medicine & Radio Pharmaceuticals Production
5.8.2 India Nuclear Medicine & Radio Pharmaceuticals Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Nuclear Medicine & Radio Pharmaceuticals Import and Export

6 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Type)
6.1 Global Nuclear Medicine & Radio Pharmaceuticals Production by Type
6.2 Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Type
6.3 Nuclear Medicine & Radio Pharmaceuticals Price by Type

7 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Application)
7.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Application
7.2 Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Application (2014-2019)

8 Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers Analysis
8.1 GE Healthcare
8.1.1 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.1.2 GE Healthcare Product Introduction, Application and Specification
8.1.3 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Philips Healthcare
8.2.1 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.2.2 Philips Healthcare Product Introduction, Application and Specification
8.2.3 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Siemens Healthcare
8.3.1 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.3.2 Siemens Healthcare Product Introduction, Application and Specification
8.3.3 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Toshiba
8.4.1 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.4.2 Toshiba Product Introduction, Application and Specification
8.4.3 Toshiba Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Hitachi
8.5.1 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.5.2 Hitachi Product Introduction, Application and Specification
8.5.3 Hitachi Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Carestream
8.6.1 Carestream Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.6.2 Carestream Product Introduction, Application and Specification
8.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Esaote
8.7.1 Esaote Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.7.2 Esaote Product Introduction, Application and Specification
8.7.3 Esaote Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Shimadzu
8.8.1 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.8.2 Shimadzu Product Introduction, Application and Specification
8.8.3 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 TriFoil Imaging
8.9.1 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.9.2 TriFoil Imaging Product Introduction, Application and Specification
8.9.3 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Biosensors International Group, Ltd
8.10.1 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
8.10.2 Biosensors International Group, Ltd Product Introduction, Application and Specification
8.10.3 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Nuclear Medicine & Radio Pharmaceuticals Market
9.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Trend Analysis
9.1.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size (Volume and Value) Forecast 2019-2025
9.2 Nuclear Medicine & Radio Pharmaceuticals Regional Market Trend
9.2.1 North America Nuclear Medicine & Radio Pharmaceuticals Forecast 2019-2025
9.2.2 Europe Nuclear Medicine & Radio Pharmaceuticals Forecast 2019-2025
9.2.3 China Nuclear Medicine & Radio Pharmaceuticals Forecast 2019-2025
9.2.4 Japan Nuclear Medicine & Radio Pharmaceuticals Forecast 2019-2025
9.2.5 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Forecast 2019-2025
9.2.6 India Nuclear Medicine & Radio Pharmaceuticals Forecast 2019-2025
9.3 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Product Type)
9.4 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Nuclear Medicine & Radio Pharmaceuticals Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Nuclear Medicine & Radio Pharmaceuticals
Table Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Types in 2018
Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals Product Picture
Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Product Picture
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Applications in 2018
Figure Diagnostic Applications: SPECT, PET.
Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) (2014-2025)
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) (2014-2025)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2014-2025)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2014-2025)
Figure China Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2014-2025)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2014-2025)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2014-2025)
Figure India Nuclear Medicine & Radio Pharmaceuticals Market Size (Million USD) (2014-2025)
Table Nuclear Medicine & Radio Pharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals in 2018
Figure Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
Figure Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Nuclear Medicine & Radio Pharmaceuticals Manufacturing Plants Distribution
Table Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Nuclear Medicine & Radio Pharmaceuticals Capacity (K Units) of Major Manufacturers (2014-2019)
Table Nuclear Medicine & Radio Pharmaceuticals Production (K Units) of Major Manufacturers (2014-2019)
Table Nuclear Medicine & Radio Pharmaceuticals Production Market Share of Major Manufacturers (2014-2019)
Figure Nuclear Medicine & Radio Pharmaceuticals Production Share by Manufacturers in 2018
Table Nuclear Medicine & Radio Pharmaceuticals Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share of Major Manufacturers (2014-2019)
Figure Nuclear Medicine & Radio Pharmaceuticals Revenue Share by Manufacturers in 2018
Table Nuclear Medicine & Radio Pharmaceuticals Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production by Regions 2014-2019 (K Units)
Table Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Regions 2014-2019
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share by Regions in 2018
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue by Regions 2014-2019 (Million USD)
Table Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions 2014-2019
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share by Regions in 2018
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption by Regions 2014-2019 (K Units)
Table Global Nuclear Medicine & Radio Pharmaceuticals Consumption Market Share by Regions 2014-2019
Figure North America Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table North America Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure China Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table China Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure India Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate 2014-2019 (K Units)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate 2014-2019 (Million USD)
Table India Nuclear Medicine & Radio Pharmaceuticals Production, Consumption Import and Export (K Units)
Figure Global Consumption Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2014-2019)
Figure Global Value (Consumption) Nuclear Medicine & Radio Pharmaceuticals Market Share by Application (2014-2019)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Toshiba Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Toshiba Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Hitachi Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Hitachi Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Carestream Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Carestream Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Esaote Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Esaote Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Shimadzu Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Shimadzu Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Sites and Area Served
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Product Introduction, Application and Specification
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate (2014-2019)
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Production Market Share (2014-2019)
Figure Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Revenue Market Share (2014-2019)
Table Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Main Business and Markets Served
Figure Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Nuclear Medicine & Radio Pharmaceuticals Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Nuclear Medicine & Radio Pharmaceuticals Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Nuclear Medicine & Radio Pharmaceuticals Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Nuclear Medicine & Radio Pharmaceuticals by Type (2019-2025)
Table Global Consumption (K Units) of Nuclear Medicine & Radio Pharmaceuticals by Application (2019-2025)
Table Nuclear Medicine & Radio Pharmaceuticals Distributors List
Table Nuclear Medicine & Radio Pharmaceuticals Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

GE Healthcare、Philips Healthcare、Siemens Healthcare、Toshiba、Hitachi、Carestream、Esaote、Shimadzu、TriFoil Imaging、Biosensors International Group, Ltd、

★調査レポート[世界の核医学＆放射性医薬品市場 2019年] (コード：DATA909X12120)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の核医学＆放射性医薬品市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 核医学システムの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103565 / GlobalInfoResearch / 2019年9月27日 / 本調査レポートは、核医学システムの世界市場について調べ、まとめました。種類別セグメントは、単一光子放出コンピュータ断層撮影（SPECT）システム、ハイブリッド陽電子放出断層撮影（PET）システム、平面シンチグラフィ等、用途別セグメントは、病院、イメージングセンター、研究所、その他等に区分しました。核医学システムの世界市場概観、メーカー動向、メーカー別核医学システムシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・核医学システムの市場概観 ・核医学システムの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・核医学システムの企業別販売動向、市場シェア、市場集中度、競争動向 ・核医学システムの世界市場規模 ・核医学システムの北米市場分析（アメリカ、カナダ、メキシコ等） ・核医学システムのアメリカ市場規模推移 ・核医学システムのカナダ市場規模推移 ・核医学システムのメキシコ市場規模推移 ・核医学システムのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Nuclear medicine is a medical specialty that uses radioactive tracers (radiopharmaceuticals) to assess bodily functions and to diagnose and treat disease. Specially designed cameras allow doctors to track the path of these radioactive tracers. Single Photon Emission Computed Tomography or SPECT and Positron Emission Tomography or PET scans are the two most common imaging modalities in nuclear medicine. Scope of the Report: The worldwide market for Nuclear Medicine System is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a...
  • 世界の核イメージングシステム市場 2019年
    DATA909X12117 / QYResearch / 2019年11月20日 / ※本調査レポートは、核イメージングシステムの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、陽電子放出断層撮影、単一光子放出コンピュータ断層撮影、平面シンチグラフィシステムに、用途別には、腫瘍学、心臓病学、神経学、その他にセグメント区分し、核イメージングシステムの世界市場を分析しました。 ・エグゼクティブ・サマリー ・核イメージングシステムの世界市場概要 ・核イメージングシステムの製造コスト構成分析 ・核イメージングシステムの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・核イメージングシステムの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・核イメージングシステムのセグメント分析（種類別） （陽電子放出断層撮影、単一光子放出コンピュータ断層撮影、平面シンチグラフィシステム）...The global Nuclear Imaging Systems market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nuclear Imaging Systems volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nuclear Imaging Systems market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Nuclear Imaging Systems in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の肺動脈高血圧症（PAH）治療薬市場 2019年
    DATA909X13888 / QYResearch / 2019年11月20日 / ※本調査レポートは、肺動脈高血圧症（PAH）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤に、用途別には、二次性肺高血圧症（SPH）、原発性肺高血圧症（PPH）にセグメント区分し、肺動脈高血圧症（PAH）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・肺動脈高血圧症（PAH）治療薬の世界市場概要 ・肺動脈高血圧症（PAH）治療薬の製造コスト構成分析 ・肺動脈高血圧症（PAH）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・肺動脈高血圧症（PAH）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・肺動脈高血圧症（PAH）治療薬のセグメント分析（種類別） （エンドセリン受容体拮抗薬（ERA）、プロスタサイクリンおよびプロスタサイクリンアナログ、ホスホジエステラーゼ5（PDE-5）、可溶性グアニル酸シクラーゼ（SGC）刺激剤）...The global Pulmonary Arterial Hypertension (PAH) Medicine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pulmonary Arterial Hypertension (PAH) Medicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Arterial Hypertension (PAH) Medicine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pulmonary Arterial Hypertension (PAH) Medicine in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の核内受容体ROR-ガンマ市場 2019年
    DATA909X12123 / QYResearch / 2019年11月20日 / ※本調査レポートは、核内受容体ROR-ガンマの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VPR-66、INV-17、GSK-2981278、BBI-6000、その他に、用途別には、病院、クリニック、その他にセグメント区分し、核内受容体ROR-ガンマの世界市場を分析しました。 ・エグゼクティブ・サマリー ・核内受容体ROR-ガンマの世界市場概要 ・核内受容体ROR-ガンマの製造コスト構成分析 ・核内受容体ROR-ガンマの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・核内受容体ROR-ガンマの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・核内受容体ROR-ガンマのセグメント分析（種類別） （VPR-66、INV-17、GSK-2981278、BBI-6000、その他）...The global Nuclear Receptor ROR-Gamma market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nuclear Receptor ROR-Gamma volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nuclear Receptor ROR-Gamma market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Nuclear Receptor ROR-Gamma in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の核医学における放射性医薬品市場 2019年
    DATA909X14070 / QYResearch / 2019年11月20日 / ※本調査レポートは、核医学における放射性医薬品の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、診断用放射性医薬品、治療用放射性医薬品、濃縮安定同位体に、用途別には、診断用、治療用、研究、医薬品、産業にセグメント区分し、核医学における放射性医薬品の世界市場を分析しました。 ・エグゼクティブ・サマリー ・核医学における放射性医薬品の世界市場概要 ・核医学における放射性医薬品の製造コスト構成分析 ・核医学における放射性医薬品の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・核医学における放射性医薬品の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・核医学における放射性医薬品のセグメント分析（種類別） （診断用放射性医薬品、治療用放射性医薬品、濃縮安定同位体）...The global Radiopharmaceuticals in Nuclear Medical market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Radiopharmaceuticals in Nuclear Medical volume and value at global level, regional level and company level. From a global perspective, this report represents overall Radiopharmaceuticals in Nuclear Medical market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Radiopharmaceuticals in Nuclear Medical in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆